Vanderford, T. H., Slichter, C., Rogers, K. A., Lawson, B. O., Obaede, R., Else, J., . . . Silvestri, G. (2012). Treatment of SIV-infected sooty mangabeys with a type-I IFN agonist results in decreased virus replication without inducing hyperimmune activation. American Society of Hematology.

Vanderford, Thomas H., Chloe Slichter, Kenneth A. Rogers, Benton O. Lawson, Rend Obaede, James Else, Francois Villinger, Steven E. Bosinger, and Guido Silvestri. Treatment of SIV-infected Sooty Mangabeys With a Type-I IFN Agonist Results in Decreased Virus Replication Without Inducing Hyperimmune Activation. American Society of Hematology, 2012.

Vanderford, Thomas H., et al. Treatment of SIV-infected Sooty Mangabeys With a Type-I IFN Agonist Results in Decreased Virus Replication Without Inducing Hyperimmune Activation. American Society of Hematology, 2012.